In this RCT, daprodustat was noninferior to darbepoetin alfa in treating anemia of chronic kidney disease. Daprodustat represents an oral alternative treatment to a conventional erythropoiesis-stimulating agent in the incident dialysis population. ja.ma/3Kon1b7

4:00 PM ยท Apr 4, 2022

0
5
0
8